Diet, fibers, and probiotics for irritable bowel syndrome

Many aspects make irritable bowel syndrome (IBS) challenging for both patients and physicians. The unclear pathogenesis with many pathways to be explored, bothering symptoms that affect the quality of life, and many subtypes of the condition are only a few reasons that make IBS difficult to control...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicine and life 2022-02, Vol.15 (2), p.174-179
Main Authors: Galica, Adelina Nicoleta, Galica, Reitano, Dumitrașcu, Dan Lucian
Format: Article
Language:English
Subjects:
Abdomen
Artificial sweeteners
Carbohydrates
Diet
Dietary fiber
Disaccharides
Fermentation
Food
Gluten
Humans
Irritable bowel syndrome
Irritable Bowel Syndrome - complications
Irritable Bowel Syndrome - therapy
Lactose
Malnutrition
Microbiota
Monosaccharides
Pathogenesis
Patients
Pharmaceuticals
Probiotics
Probiotics - therapeutic use
Quality of Life
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Many aspects make irritable bowel syndrome (IBS) challenging for both patients and physicians. The unclear pathogenesis with many pathways to be explored, bothering symptoms that affect the quality of life, and many subtypes of the condition are only a few reasons that make IBS difficult to control and obtain satisfactory results. Treatment options start with general advice for lifestyle, continue with non-pharmaceutical treatments, and finally touch classic treatments. In this review, pharmaceutical treatment options are not accounted for. Consensus groups and meta-analyses have concluded guidelines that overall are the same, with variations in the strength of recommendations and some cultural and geographical particularities. Dietary interventions, probiotics, and fibers can be seen as non-pharmaceutical treatments that coexist in various protocols because of the relevant evidence regarding their efficacy in treating IBS symptoms.
ISSN:1844-122X
1844-3117
DOI:10.25122/jml-2022-0028